Hans Lilja
251 – 260 of 459
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy
(
- Contribution to journal › Article
-
Mark
Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective
(
- Contribution to journal › Article
-
Mark
Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
(
- Contribution to journal › Article
-
Mark
A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue.
(
- Contribution to journal › Article
-
Mark
Novel homogenous time-resolved fluorometric RT-PCR assays for quantification of PSA and hK2 mRNAs in blood
(
- Contribution to journal › Article
-
Mark
Circulating biomarkers for prostate cancer
(
- Contribution to journal › Article
-
Mark
Measurements of proteases or protease system components in blood to enhance prediction of disease risk or outcome in possible cancer
(
- Contribution to journal › Article
-
Mark
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer - Results from a prospective, population-based randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer
(
- Contribution to journal › Article